Details for New Drug Application (NDA): 202462
✉ Email this page to a colleague
The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
Summary for 202462
Tradename: | CHLOROTHIAZIDE SODIUM |
Applicant: | Sagent Pharms Inc |
Ingredient: | chlorothiazide sodium |
Patents: | 0 |
Pharmacology for NDA: 202462
Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 202462
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202462 | ANDA | Sagent Pharmaceuticals | 25021-305 | 25021-305-66 | 1 VIAL in 1 CARTON (25021-305-66) / 18 mL in 1 VIAL |
CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202462 | ANDA | Sagent Pharmaceuticals | 25021-305 | 25021-305-20 | 1 VIAL in 1 CARTON (25021-305-20) / 18 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | May 29, 2015 | TE: | AP | RLD: | No |
Complete Access Available with Subscription